Promotie onderzoek

Filter op:

Onderwerp

Universiteit

KNMP stelt wetenschappelijk onderzoek voorop. Hier kunt u de meest recente onderzoeken vinden.
Er zijn26resultaten gevonden
Klinische farmacologie

LIMONCELLO: medication reviews and transitional care

  • Universiteit Radboud UMC Nijmegen
  • Promovendus Sjacky Cooijmans
  • Promoters Kees Kramer, Patricia van den Bemt
  • Co-Promoters Wilma Knol, Noortje van Herwaarden
  • Jaar 2019-2025
Farmaco-economie

Cost containment strategies of expensive drugs from a university hospital persective

  • Universiteit Erasmus Medisch Centrum Rotterdam
  • Promovendus Aniek Dane
  • Promoters Hugo van der Kuy Carin Uyl-de Groot
  • Jaar 2020-2024

The aim is to present current and new strategies university hospitals can undertake to contain costs of expensive drugs using a drug life cycle approach.
 

Farmaco-economie

Towards sustainable oncology care: Optimizing the utilization of healthcare resources in oncology

  • Universiteit Erasmus Medisch Centrum Rotterdam
  • Promovendus Michiel Zietse
  • Promoters Birgit Koch Ron Mathijssen
  • Co-Promoters Roelof van Leeuwen Frederick Thielen
  • Jaar 2023-2027

To explore and implement strategies for optimizing healthcare resource utilization in oncology, with the aim of advancing the (financial) sustainability in oncology care.
 

Farmaco-economie

Cost-effectiveness of expensive drugs

  • Universiteit Erasmus Medisch Centrum Rotterdam
  • Promovendus Shannon van der Zeeuw
  • Promoters P.H.M. van der Kuy
  • Co-Promoters M.B.S. Crombag T. Preijers
  • Jaar 2024-2028

Hospital expenditure of expensive drugs increases yearly. In addition, shortages are becoming more common. To assure access to healthcare and treatment in the future, sustainable use of expensive drugs is very important. This research aims to optimize treatment with regard to efficacy and safety, while aiming to reduce drug costs. 
 

Klinische farmacologie

Boosting van olaparib

  • Universiteit Radboud UMC Nijmegen
  • Promovendus Joanneke Overbeek
  • Promoters Nielka van Erp Haiko Bloemendal
  • Co-Promoters Rob ter Heine
  • Jaar 2021-2025

Het doel is het effect van farmacokinetische boosting op de farmacokinetiek, effectiviteit en toxiciteit van behandeling met olaparib te onderzoeken.

Pagina 4 van 4